EUVIMEDEUVIMED entdecken
ValidierungsstudieOpen Access

Development and Validation of a Brief Age-Normed Screening Tool for Subthreshold Psychosis Symptoms in Youth

Monica E Calkins iD, Arielle Ered iD, Tyler M Moore, Lauren K White, Jerome Taylor, Alexander B Moxam, Kosha Ruparel, Daniel H Wolf, Theodore D Satterthwaite, Christian G Kohler, Ruben C Gur, Raquel E Gur

Schizophrenia Bulletin · 2025

DOI: 10.1093/schbul/sbae224 ↗

Kurz gefasst

Validierungsstudie in der Zeitschrift Schizophrenia Bulletin, 2025. Verfasst von Monica E Calkins und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, Neurodevelopment and Psychosis Section, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United S…. Hauptthemen laut MEDLINE: Psychotic Disorders, Prodromal Symptoms, Psychiatric Status Rating Scales, Psychometrics. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Lifespan Brain Institute, NIMH NIH HHS, National Institute of Mental Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Hypothesis Improvements in screening tools for early subthreshold psychosis symptoms are needed to facilitate early identification and intervention efforts, especially given the challenges of rapidly differentiating age-appropriate experiences from potential early signs of emerging psychosis. Tools can be lengthy and time-consuming, impacting their utility and accessibility across clinical settings, and age-normed data are limited. To address this gap, we sought to develop and validate a brief, empirically derived, age-normed, subthreshold psychosis screening tool, for public use. Study Design Computerized adaptive test simulation was used to derive a 5-item short form with age norm equivalencies from a 12-item PRIME-Screen-Revised (PRIME-12) administered to 7053 youth (Mage = 15.8, SD = 2.7; 54% female; 33% Black). Concurrent validity was assessed (n = 758) using contemporaneous administration of the PRIME-5 and the Structured Interview for Prodromal Syndromes. Comparability of criterion-related validity of the PRIME-5, PRIME-12, and Scale of Prodromal Symptoms (SOPS) was assessed by relating scores to psychosis-risk-relevant criteria. Finally, self-report versus assessor-administered PRIME total scores were compared (n = 131) to assess their concurrent validity. Study Results Correlations among PRIME-5, PRIME-12, and SOPS were comparable and moderate, supporting their convergent validity. The PRIME-5 also showed comparable criterion-related validity, demonstrating similar relationships with psychosis-risk indicators as the other tools. Self-reported and assessor-administered PRIME-5 were moderately correlated. Conclusions Public availability of a brief, age-normed, and validated screening tool—which can be assessor or self-administered—will expedite and improve early identification of youth (age 11 and older) at risk for psychosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Psychotic DisordersProdromal SymptomsPsychiatric Status Rating ScalesPsychometricsHumansAdolescentFemaleMaleYoung AdultReproducibility of ResultsChildAdult

Stichwörter der Autor:innen

age-normedcommunity youthpsychosis-spectrum symptomssubthreshold psychosis screen

Autor:innen und Institutionen

  • Department of Psychiatry, Neurodevelopment and Psychosis Section, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States.
  • Lifespan Brain Institute of Penn and CHOP, Philadelphia, PA, United States.
  • Department of Child and Adolescent Psychiatry and Behavioral Sciences, Children's Hospital of Philadelphia, Philadelphia, PA, United States.

ORCID-Profile: Monica E Calkins, Arielle Ered

Förderung

  • Lifespan Brain Institute
  • NIMH NIH HHS
  • National Institute of Mental Health

Zitieren

APA

Calkins, M. E., Ered, A., Moore, T. M., White, L. K., Taylor, J., Moxam, A. B., Ruparel, K., Wolf, D. H., Satterthwaite, T. D., Kohler, C. G., Gur, R. C., & Gur, R. E. (2025). Development and Validation of a Brief Age-Normed Screening Tool for Subthreshold Psychosis Symptoms in Youth. Schizophrenia Bulletin. https://doi.org/10.1093/schbul/sbae224

Vancouver

Calkins ME, Ered A, Moore TM, White LK, Taylor J, Moxam AB, et al. Development and Validation of a Brief Age-Normed Screening Tool for Subthreshold Psychosis Symptoms in Youth. Schizophrenia Bulletin. 2025. doi:10.1093/schbul/sbae224

BibTeX
@article{Calkins2025,
  author = {Calkins, Monica E and Ered, Arielle and Moore, Tyler M and White, Lauren K and Taylor, Jerome and Moxam, Alexander B and Ruparel, Kosha and Wolf, Daniel H and Satterthwaite, Theodore D and Kohler, Christian G and Gur, Ruben C and Gur, Raquel E},
  title = {Development and Validation of a Brief Age-Normed Screening Tool for Subthreshold Psychosis Symptoms in Youth},
  journal = {Schizophrenia Bulletin},
  year = {2025},
  doi = {10.1093/schbul/sbae224}
}
Kostenlos starten →